Kidney Transplant Recipients. Other complication of kidney transplant
Conditions
Interventions
Intervention 1: Intervention group: Receiving a standard dose of seasonal influenzae tetravalent vaccine (15µg of Hemophilus Influenza Antigen). This 2021-2022 vaccine is inactivated and is made by th
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: At least 18 years old At least three months have passed since their transplant.
Exclusion criteria
Exclusion criteria: Treatment for acute transplantation reject Acute febrile illness in the last two weeks Previous life-threatening reactions to vaccine products (such as Guillain-Barré syndrome) Patients with any autoimmune disease receiving corticosteroids or immunosuppressive drugs. Patients who have recently underwent kidney transplant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Influenza A's Antibody. Timepoint: Before intervention and four weeks after vaccination. Method of measurement: Evaluating the influenzas' antibodies by serology.;Influenza B's Antibody. Timepoint: Before intervention and four weeks after vaccination. Method of measurement: Evaluating the influenzas' antibodies by serology. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: 3 days after injection. Method of measurement: Clinical Examination.;Getting the flu. Timepoint: 3 days after injection. Method of measurement: Evaluation of the patient's clinical symptoms.;Existence of pain at the injection site. Timepoint: 3 days after injection. Method of measurement: Clinical Examination.;Redness at the injection site. Timepoint: 3 days after injection. Method of measurement: Clinical Examination.;Systemic side effects. Timepoint: 3 days after injection. Method of measurement: Clinical Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedAhmad SeyedAlinaghi
Tehran University of Medical Sciences
Outcome results
None listed